Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.

Intracoronary bolus Abciximab single is non-inferior to intravenous and continuous 12- hours infusion in the size reduction of infarction on cardiac magnetic resonance in Non-ST elevation Myocardial infarction.

Inclusion Criteria:

• non-ST segment elevation acute myocardial infarction
• within 48 hours presence of chest pain
• Troponin-T or I positive before CAG
• First myocardial infarction
• will be performed coronary angioplasty

Exclusion Criteria:

• under 18 years of age,80 years or older
• Bleeding tendency
• History of major surgery within 4 weeks
• Major stroke within 2 years
• Thrombocytopenia (<120,000 / uL)
• Cardiogenic shock
• Known allergy to aspirin, heparin, or abciximab
• Contraindication of MRI at study entry (implanted pacemakers, defibrillators, intracranial metallic implants etc)
• Chronic atrial fibrillation
• Pregnancy